Solaris Technology sets up head office at BioCity Nottingham

Solaris Technology has set up its headquarters at BioCity Nottingham following a £250,000 investment from the MEIF Proof of Concept & Early Stage Fund, managed by Mercia and part of the Midlands Engine Investment Fund.

The investment will help the firm finalise global manufacturing and distribution agreements, while also supporting the development of a sales and marketing strategy.

Background

Founded in 2016, Solaris Technology is led by Managing Director Dr Jonathan Hibbard, the chemist who developed the technology, CEO Alaric Errington and Sales and Marketing Director Jon Kenyon-Smith. The company’s innovative coating system, SolarBlock, blocks unwanted solar heat gain and the sun’s damaging rays without reducing natural light.

As a result of this £250,000 investment, the company has now established its head office and research and development facility at BioCity Nottingham.

Investing in the future

Jonathan Hibbard, Managing Director of Solaris Technology, explains: “Bringing disruptive new technologies such as SolarBlock to market requires heavy investment in research and development. This support will allow us to accelerate the commercialization phase, establish a global infrastructure and grow the business more quickly.”

David Baker, Investment Associate with Mercia Fund Managers, said: “Solaris Technology has developed a very exciting product in SolarBlock and one that has the potential to disrupt a worldwide industry with an estimated value of £80 billion. The funding will allow it to finalise agreements with existing partners, which will generate commercial revenues and unlock opportunities for significant sustained growth.”